Most medical treatments face a fundamental timing problem: the body’s needs change as healing progresses. A single dose of medication often creates a "peaks and valleys" effect, where drug concentrations are initially too high (causing side effects) and later too low (losing efficacy). To solve this, researchers are developing biphasic release systems—delivery vehicles engineered to provide an immediate "burst" of medication followed by a long-term, sustained "maintenance" dose.
The Logic of the Two-Phase Profile
The core intuition behind a biphasic system is the separation of therapeutic intent into two distinct stages. The first stage, often called the burst release, aims to reach a therapeutic threshold rapidly. This is critical in conditions like periodontal disease, where Hiroshi Okada and colleagues demonstrated that an initial high dose of ofloxacin can significantly reduce infection markers before mechanical cleaning even begins (Topical application of the controlled release strips containing ofloxacin(PT-01) in periodontal therapy.).
The second stage, the sustained release, maintains that concentration over days or weeks. This is achieved by manipulating the physical chemistry of the carrier. For example, Xiangyang Xie showed that in PLGA microspheres, the initial release is driven by simple surface diffusion, while the long-term release is governed by the gradual "bulk erosion" or degradation of the polymer matrix itself (In Vitro and In Vivo Evaluations of PLGA Microspheres Containing Nalmefene). This dual-action ensures the drug payload isn't depleted all at once.
Architectural Strategies for Temporal Control
To achieve these distinct phases, researchers use hierarchical or compartmentalized architectures. Rather than a uniform pill, these systems are "sandwiches" or "nested dolls" of different materials.
- Surface vs. Internal Distribution: By placing drug particles both on the surface and within a polymer matrix, HM Ji created transdermal patches that offer both rapid onset and long-term relief (Penetration Enhancement Effect of Turpentine Oil on Transdermal Film of Ketorolac).
- Layered Films: In Traditional Chinese Medicine applications, Qianhang Li describes multi-layered film architectures where outer layers provide immediate relief while internal layers protect volatile compounds for later release (Application of traditional Chinese medicine in film drug delivery system).
- Nested Carriers: A sophisticated approach involves embedding drug-loaded nanoparticles or microspheres inside a larger hydrogel scaffold. Ruizhi Zhang utilized this for spinal cord repair, using the bulk hydrogel for immediate delivery and embedded microspheres for the "slow-burn" phase (Dual-phase SilMA hydrogel: a dynamic scaffold for sequential drug release and enhanced spinal cord repair via neural differentiation and immunomodulation).
Matching Biological Rhythms
The ultimate goal of these systems is to synchronize drug availability with the biological stages of tissue repair. Healing is rarely a single event; it is a sequence of inflammation, cell proliferation, and eventual maturation.
In bone regeneration, Zhi Hong Chen developed a system that releases vascular growth factors in an initial burst to kickstart blood vessel formation, followed by a slow release of mineral ions to support long-term bone growth (Injectable Composite Hydrogel Stents for Bone Defect Management with Enhanced Osteogenesis and Angiogenesis). Similarly, Muzhe Li used a dual-phase profile to first address acute post-surgical inflammation in the meniscus before transitioning to a regenerative phase (STS delivery PCL-MECM based hydrogel hybrid scaffold promote meniscal regeneration through controlling the phenotype of macrophages).
This "programmed" approach moves pharmacology away from static dosing and toward dynamic, time-aware therapy. By engineering the delivery vehicle to mimic the body's own healing timeline, researchers can maximize therapeutic impact while minimizing the frequency of administration.